The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Open accessAbstract
It is well-established that the chemokine C-X-C motif ligand 13 (CXCL13) and its receptor, the G-protein coupled receptor (GPCR) CXCR5, play fundamental roles in inflammatory, infectious and immune responses. Originally identified as a B-cell chemoattractant, CXCL13 exerts important functions in lymphoid neogenesis, and has been widely implicated in the pathogenesis of a number of autoimmune diseases and inflammatory conditions, as well as in lymphoproliferative disorders. Current evidence also indicates that the CXCL13:CXCR5 axis orchestrates cell-cell interactions that regulate lymphocyte infiltration within the tumor microenvironment, thereby determining responsiveness to cytotoxic and immune-targeted therapies. In this review, we provide a comprehensive perspective of the involvement of CXCL13 and its receptor in cancer progression. Studies in recent years postulated novel roles for this chemokine in controlling the cancer cell phenotype, and suggest important functions in the growth and metastatic dissemination of solid tumors. Carcinogens have been found to induce CXCL13 production, and production of this chemokine within the tumor milieu has been shown to impact the proliferation, migration, and invasive properties of cancer cells. Thus, the complex networks of cellular interactions involving tumoral CXCL13 and CXCR5 integrate to promote cancer cell autonomous and non-autonomous responses, highlighting the relevance of autocrine and paracrine interactions in dictating the cancer phenotype. Dissecting the molecular and signaling events regulated by CXCL13 and how this chemokine dynamically controls the interaction between the cancer cell and the tumor microenvironment is key to identify novel effectors and therapeutic targets for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.49 · Cited by 2,206
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
T follicular helper cell biology: a decade of discovery and diseases
Crotty, S. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.011 · Cited by 1,591
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
Schall, T. J., Bacon, K., Toy, K. J., & Goeddel, D. V. (1990) · Nature · doi:10.1038/347669a0 · Cited by 1,379
Thommen, D. S., Koelzer, V. H., Herzig, P., Roller, A., Trefny, M., Dimeloe, S., Kiialainen, A., Hanhart, J., Schill, C., Hess, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0057-z · Cited by 1,161
Förster, R., Mattis, A. E., Kremmer, E., Wolf, E., Brem, G., & Lipp, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81798-5 · Cited by 1,129
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Legler, D. F., Loetscher, M., Roos, R. S., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.655 · Cited by 837
A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
Gunn, M. D., Ngo, V. N., Ansel, K. M., Ekland, E. H., Cyster, J. G., & Williams, L. T. (1998) · Nature · doi:10.1038/35876 · Cited by 835
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3700 · Cited by 698
A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
Subramanian, S., Tus, K., Li, Q.-Z., Wang, A., Tian, X.-H., Zhou, J., Liang, C., Bartov, G., McDaniel, L. D., Zhou, X. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603912103 · Cited by 651
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
Perreau, M., Savoye, A.-L., De Crignis, E., Corpataux, J.-M., Cubas, R., Haddad, E. K., De Leval, L., Graziosi, C., & Pantaleo, G. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121932 · Cited by 630
Tertiary lymphoid structures in cancer and beyond
Dieu-Nosjean, M.-C., Goc, J., Giraldo, N. A., Sautès-Fridman, C., & Fridman, W. H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.09.006 · Cited by 617
Yoshimura, T., Matsushima, K., Oppenheim, J. J., & Leonard, E. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.3.788 · Cited by 610
Rollins, B. J. (1997) · PubMed · Cited by 603
Follicular helper T cells are required for systemic autoimmunity
Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L., Cook, M. C., Walters, G. D., & Vinuesa, C. G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081886 · Cited by 587
A brief history of T cell help to B cells
Crotty, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3803 · Cited by 553
T Cell Activation in Rheumatoid Synovium Is B Cell Dependent
Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., & Weyand, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4710 · Cited by 536
Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R.-M. T., Davis, B. K., Uronis, J. M., Herfarth, H. H., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.012 · Cited by 534
Amft, N., Curnow, S. J., Scheel-Toellner, D., Devadas, A., Oates, J., Crocker, J., Hamburger, J., Ainsworth, J., Mathews, J., Salmon, M., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2633::aid-art443>3.0.co;2-9 · Cited by 471
Siliņa, K., Soltermann, A., Attar, F. M., Casanova, R., Uckeley, Z. M., Thut, H., Wandres, M., Isajevs, S., Cheng, P., Curioni-Fontecedro, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1987 · Cited by 448
Schröder, A. E., Greiner, A., Seyfert, C., & Berek, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.221 · Cited by 434
Expansion of HIV-specific T follicular helper cells in chronic HIV infection
Lindqvist, M., van Lunzen, J., Soghoian, D. Z., Kuhl, B. D., Ranasinghe, S., Kranias, G., Flanders, M. D., Cutler, S., Yudanin, N., Muller, M. I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64314 · Cited by 418
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
Dieu‐Nosjean, M., Giraldo, N. A., Kaplon, H., Germain, C., Fridman, W. H., & Sautès‐Fridman, C. (2016) · Immunological Reviews · doi:10.1111/imr.12405 · Cited by 417
Laing, K. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.006 · Cited by 417
The chemokine system and cancer
Balkwill, F. R. (2012) · The Journal of Pathology · doi:10.1002/path.3029 · Cited by 412
IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Pylayeva-Gupta, Y., Das, S., Handler, J. S., Hajdu, C. H., Coffre, M., Koralov, S. B., & Bar-Sagi, D. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0843 · Cited by 357
Corcione, A., Casazza, S., Ferretti, E., Giunti, D., Zappia, E., Pistorio, A., Gambini, C., Mancardi, G. L., Uccelli, A., & Pistoia, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402455101 · Cited by 349
de Chaisemartin, L., Goc, J., Damotte, D., Validire, P., Magdeleinat, P., Alifano, M., Cremer, I., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0952 · Cited by 338
Mazzucchelli, L., Blaser, A., Kappeler, A., Schärli, P., Laissue, J. A., Baggiolini, M., & Uguccioni, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7830 · Cited by 300
Shi, K., Hayashida, K., Kaneko, M., Hashimoto, J., Tomita, T., Lipsky, P. E., Yoshikawa, H., & Ochi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.650 · Cited by 280
Mechanisms of Regulation of the Chemokine-Receptor Network
Stone, M., Hayward, J., Huang, C., E. Huma, Z., & Sanchez, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020342 · Cited by 275
B cell and B cell-related pathways for novel cancer treatments
Tokunaga, R., Naseem, M., Lo, J. H., Battaglin, F., Soni, S., Puccini, A., Berger, M. D., Zhang, W., Baba, H., & Lenz, H.-J. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.12.001 · Cited by 247
Dupuis, J., Boye, K., Martin, N., Copie-Bergman, C., Plonquet, A., Fabiani, B., Baglin, A.-C., Haioun, C., Delfau-Larue, M.-H., & Gaulard, P. (2006) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200604000-00009 · Cited by 236
Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia
Lee, K. E., Spata, M., Bayne, L. J., Buza, E. L., Durham, A. C., Allman, D., Vonderheide, R. H., & Simon, M. C. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0822 · Cited by 227
CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
Rubenstein, J. L., Wong, V. S., Kadoch, C., Gao, H.-X., Barajas, R., Chen, L., Josephson, S. A., Scott, B., Douglas, V., Maiti, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-476333 · Cited by 223
Circulating Inflammation Markers and Prospective Risk for Lung Cancer
Shiels, M. S., Pfeiffer, R. M., Hildesheim, A., Engels, E. A., Kemp, T. J., Park, J.-H., Katki, H. A., Koshiol, J., Shelton, G., Caporaso, N. E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt309 · Cited by 222
Goetzl, E. J., & Austen, K. F. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.10.4123 · Cited by 217
Yau, C., Esserman, L., Moore, D. H., Waldman, F., Sninsky, J., & Benz, C. C. (2010) · Breast Cancer Research · doi:10.1186/bcr2753 · Cited by 212
Bürkle, A., Niedermeier, M., Schmitt-Gräff, A., Wierda, W. G., Keating, M. J., & Burger, J. A. (2007) · Blood · doi:10.1182/blood-2007-05-089409 · Cited by 211
Ammirante, M., Shalapour, S., Kang, Y., Jamieson, C. A. M., & Karin, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416498111 · Cited by 206
Smith, J. R., Braziel, R. M., Paoletti, S., Lipp, M., Uguccioni, M., & Rosenbaum, J. T. (2003) · Blood · doi:10.1182/blood-2002-05-1576 · Cited by 196
Altman, L. C., Snyderman, R., Oppenheim, J. J., & Mergenhagen, S. E. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.110.3.801 · Cited by 186
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S., Lidereau, R., & Lazennec, G. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01301 · Cited by 183
Salomonsson, S., Larsson, P., Tengnér, P., Mellquist, E., Hjelmström, P., & Wahren‐Herlenius, M. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01058.x · Cited by 172
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C., & Berrih-Aknin, S. (2006) · Blood · doi:10.1182/blood-2005-06-2383 · Cited by 172
Jones, G. W., Hill, D. G., & Jones, S. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00401 · Cited by 169
Differentiation‐specific expression of a novel G protein‐coupled receptor from Burkitt's lymphoma
Dobner, T., Wolf, I., Emrich, T., & Lipp, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221107 · Cited by 158
Chemokines and cancer: new immune checkpoints for cancer therapy
Karin, N. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.004 · Cited by 158
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation
von Hundelshausen, P., Agten, S. M., Eckardt, V., Blanchet, X., Schmitt, M. M. N., Ippel, H., Neideck, C., Bidzhekov, K., Leberzammer, J., Wichapong, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6650 · Cited by 152
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis
Szekanecz, Z., & Koch, A. E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.157 · Cited by 151
Jones, G. W., & Jones, S. A. (2015) · Immunology · doi:10.1111/imm.12554 · Cited by 146
CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
Zhu, Z., Zhang, X., Guo, H., Fu, L. L., Pan, G., & Sun, Y. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2285-y · Cited by 140
Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Bartels, K., Horn, C., Stahl, T., Cao, Y. W., Milde‐Langosch, K., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604621 · Cited by 132
Szabó, K., Papp, G., Szántó, A., Tarr, T., & Zeher, M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12703 · Cited by 131
Rupprecht, T. A., Manz, K. M., Fingerle, V., Lechner, C., Klein, M., Pfirrmann, M., & Koedel, U. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.04.007 · Cited by 129
Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis
Yuan, H., Zhou, S., Liu, Z., Cong, W., Fei, X., Zeng, W., Zhu, H., Xu, R., Wang, Y., Zheng, J., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.032 · Cited by 127
Kramer, J. M., Klimatcheva, E., & Rothstein, T. L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113036 · Cited by 122
Zheng, Z., Cai, Y., Chen, H., Chen, Z., Zhu, D., Zhong, Q., & Xie, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00682 · Cited by 115
Ziarek, J. J., Kleist, A. B., London, N., Raveh, B., Montpas, N., Bonneterre, J., St‐Onge, G., DiCosmo-Ponticello, C. J., Koplinski, C. A., Roy, I., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah5756 · Cited by 104
Lee, H.-T., Shiao, Y.-M., Wu, T.-H., Chen, W., Hsu, Y., Tsai, S., & Tsai, C. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090450 · Cited by 101
Garg, R., Blando, J. M., Pérez, C. J., Abba, M. C., Benavides, F. J., & Kazanietz, M. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.042 · Cited by 101
Self-citationMeijer, J. M., Zeelenberg, I. S., Sipos, B., & Roos, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1507 · Cited by 100
Singh, S., Singh, R., Sharma, P., Singh, U. P., Rai, S. N., Chung, L. W. K., Cooper, C. R., Novakovic, K. R., Grizzle, W. E., & Lillard, J. W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.022 · Cited by 99
CXCR5, the Defining Marker for Follicular B Helper T (TFH) Cells
Moser, B. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00296 · Cited by 97
Wang, G., Cheng, X., Zhou, B., Wen, Z., Huang, Y., Chen, H.-B., Li, G., Huang, Z.-L., Zhou, Y., Feng, L., et al. (2015) · eLife · doi:10.7554/elife.09419 · Cited by 95
Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
Pierson, S. K., Stonestrom, A. J., Shilling, D., Ruth, J., Nabel, C. S., Singh, A., Ren, Y., Stone, K., Li, H., van Rhee, F., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25123 · Cited by 90
Cagigi, A., Mowafi, F., Dang, L. V. P., Tenner‐Racz, K., Atlas, A., Grützmeier, S., Rácz, P., Chiodi, F., & Nilsson, A. (2008) · Blood · doi:10.1182/blood-2008-02-140426 · Cited by 90
El-Haibi, C. P., Singh, R., Sharma, P., Singh, S., & Lillard, J. W. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00757.x · Cited by 87
Constitutive noncanonical NFκB signaling in pancreatic cancer cells
Wharry, C. E., Haines, K. M., Carroll, R. G., & May, M. J. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.8961 · Cited by 84
Schmidt, M., Weyer‐Elberich, V., Hengstler, J. G., Heimes, A.-S., Almstedt, K., Gerhold‐Ay, A., Lebrecht, A., Battista, M. J., Hasenburg, A., Şahin, U., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0942-x · Cited by 80
Cohen, K. W., Altfeld, M. A., Alter, G., & Stamatatos, L. (2014) · Journal of Virology · doi:10.1128/jvi.02186-14 · Cited by 79
Chemokine isoforms and processing in inflammation and immunity
Proost, P., Struyf, S., Damme, J. V., Fiten, P., Ugarte-Berzal, E., & Opdenakker, G. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.009 · Cited by 78
Serum Levels of the Homeostatic B Cell Chemokine, CXCL13, Are Elevated During HIV Infection
Widney, D. P., Breen, E. C., Boscardin, W. J., Kitchen, S. G., Alcantar, J. M., Smith, J. B., Zack, J. A., Detels, R., & Martı́nez-Maza, O. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.702 · Cited by 77
Husson, H., Freedman, A. S., Cardoso, A. A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03832.x · Cited by 74
A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis
Liu, W., Peng, Y., & Tobin, D. J. (2013) · PeerJ · doi:10.7717/peerj.49 · Cited by 73
Aust, G., Sittig, D. F., Becherer, L., Anderegg, U., Schutz, A., Lamesch, P., & Schmücking, E. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500225 · Cited by 73
Criscitiello, C., Bayar, M. A., Curigliano, G., Symmans, W. F., Desmedt, C., Bonnefoi, H. R., Sinn, B. V., Pruneri, G., Vicier, C., Pierga, J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx691 · Cited by 71
COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer
Garg, R., Blando, J. M., Pérez, C. J., Lal, P., Feldman, M. D., Smyth, E. M., Ricciotti, E., Großer, T., Benavides, F. J., & Kazanietz, M. G. (2018) · Oncogene · doi:10.1038/s41388-018-0318-9 · Cited by 70
Self-citationKaiser, E. A., Förster, R., Wolf, I., Ebensperger, C., Kuehl, W. M., & Lipp, M. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231023 · Cited by 69
Activation of Nuclear Factor κB (NF-κB) in Prostate Cancer Is Mediated by Protein Kinase C ϵ (PKCϵ)
Garg, R., Blando, J. M., Pérez, C. J., Wang, H., Benavides, F. J., & Kazanietz, M. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398925 · Cited by 66
Self-citationGene expression profiling in human gastric mucosa infected with Helicobacter pylori
Hofman, V., Moreilhon, C., Brest, P., Lassalle, S., Lebrigand, K., Sicard, D., Raymond, J., Lamarque, D., Hébuterne, X., Mari, B. P., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800930 · Cited by 65
El-Haibi, C. P., Sharma, P., Singh, R., Johnson, P. R., Suttles, J., Singh, S., & Lillard, J. W. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-85 · Cited by 65
Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer
Olsen, R. S., Nijm, J., Andersson, R. E., Dimberg, J., & Wågsäter, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i34.6212 · Cited by 63
CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow
Airoldi, I., Cocco, C., Morandi, F., Prigione, I., & Pistoia, V. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0392-2 · Cited by 60
Sambandam, Y., Sundaram, K., Liu, A., Kirkwood, K. L., Ries, W. L., & Reddy, S. V. (2012) · Oncogene · doi:10.1038/onc.2012.24 · Cited by 58
CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
Wang, C., Wu, K., Yu, Q., Zhang, S., Gao, Z., Liu, Y., Ni, L., Cheng, Y., Guan, Z., Shi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33569 · Cited by 57
Yu, Q., Cheng, Y., Wang, Y., Wang, C., Lu, H., Guan, Z., Huang, J., Gong, W., Shi, M., Ni, L., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix233 · Cited by 57
Chen, L., Huang, Z., Yao, G., Lyu, X., Li, J., Hu, X., Cai, Y., Li, W., Li, X., & Ye, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0521-1 · Cited by 55
CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
Mehraj, V., Ramendra, R., Isnard, S., Dupuy, F. P., Lebouché, B., Costiniuk, C. T., Thomas, R., Szabo, J., Baril, J.-G., Trottier, B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00289 · Cited by 55
Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions
Benavides, F. J., Blando, J. M., Pérez, C. J., Garg, R., Conti, C. J., DiGiovanni, J., & Kazanietz, M. G. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14469 · Cited by 53
Self-citationp53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells
Mitkin, N. A., Hook, C., Schwartz, A. M., Biswas, S., Кочетков, Д. В., Muratova, A. M., Afanasyeva, M., Kravchenko, J. E., Bhattacharyya, A., & Kuprash, D. V. (2015) · Scientific Reports · doi:10.1038/srep09330 · Cited by 52
Wei, Y., Lin, C., Li, H., Xu, Z., Wang, J., Li, R., Liu, H., Zhang, H., He, H., & Xu, J. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2083-y · Cited by 52
Sorrentino, C., Ciummo, S. L., Cipollone, G., Caputo, S., Bellone, M., & Carlo, E. D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3117 · Cited by 52
Sun, Y., Tian, H., & Wang, L. (2015) · Oncology Reports · doi:10.3892/or.2015.3804 · Cited by 51
Nariţa, D., Șeclăman, E. P., Anghel, A., Ilina, R. Ş., Cireap, N., Negru, S. M., Sîrbu, I. O., Ursoniu, S., & Marian, C. (2015) · Neoplasma · doi:10.4149/neo_2016_017 · Cited by 51
Chemokine Network and Overall Survival inTP53Wild-Type and Mutant Ovarian Cancer
Ignacio, R. M. C., Lee, E.-S., Wilson, A. J., Beeghly-Fadiel, A. C., Whalen, M. M., & Son, D. (2018) · Immune Network · doi:10.4110/in.2018.18.e29 · Cited by 50
Galamb, O., Győrffy, B., Sípos, F., Dinya, E., Krenács, T., Berczi, L., Szőke, D., Spisák, S., Solymosi, N., Németh, A. M., et al. (2008) · Helicobacter · doi:10.1111/j.1523-5378.2008.00584.x · Cited by 48
Sun, Y., Wang, L., Jiang, M., Huang, J., Liu, Z., & Wölfl, S. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9071-6 · Cited by 47
Meshki, J., Caino, M. C., von Burstin, V. A., Griner, E., & Kazanietz, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128371 · Cited by 44
Self-citationPKCϵ Is an Essential Mediator of Prostate Cancer Bone Metastasis
Gutiérrez-Uzquiza, Á., López‐Haber, C., Jernigan, D. L., Fatatis, A., & Kazanietz, M. G. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0111 · Cited by 42
Self-citationHas CXCL13 an Added Value in Diagnosis of Neurosyphilis?
Mothapo, K. M., Verbeek, M. M., van der Velden, L. B., Ang, C. W., Koopmans, P. P., van der Ven, A. J. A. M., & Stelma, F. F. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02917-14 · Cited by 42
A Novel Function of CXCL13 to Stimulate RANK Ligand Expression in Oral Squamous Cell Carcinoma Cells
Sambandam, Y., Griffin, A. C., Sundaram, K., Kirkwood, K. L., Norris, J. S., & Reddy, S. V. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0589 · Cited by 42
Pandruvada, S. N. M., Sambandam, Y., Liu, X., Sundaram, K., Shanmugarajan, S., Ries, W. L., Norris, J. S., London, S. D., & Reddy, S. V. (2009) · International Journal of Cancer · doi:10.1002/ijc.24920 · Cited by 41
Duan, Z., Gao, J., Zhang, L., Liang, H. L., Huang, X., Xu, Q., Zhang, Y. X., Shen, T., & Lu, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6235 · Cited by 40
Barella, L., Loetscher, M., Tobler, A., Baggiolini, M., & Moser, B. (1995) · Biochemical Journal · doi:10.1042/bj3090773 · Cited by 38
Eide, H., Halvorsen, A. R., Sandhu, V., Fåne, A., Berg, J., Haakensen, V. D., Kure, E. H., Brustugun, O. T., Kiserud, C. E., Kyte, J. A., et al. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.65 · Cited by 38
Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer
Heimes, A.-S., Madjar, K., Edlund, K., Battista, M. J., Almstedt, K., Elger, T., Krajnak, S., Rahnenführer, J., Brenner, W., Hasenburg, A., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4327-0 · Cited by 38
The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
Li, C., Kang, D., Sun, X., Liu, Y., Wang, J., & Gao, P. (2015) · BioMed Research International · doi:10.1155/2015/345413 · Cited by 37
Fan, L., Zhu, Q., Liu, L., Zhu, C., Huang, H., Lu, S., & Liu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18387 · Cited by 31
Biswas, S., Chowdhury, S. R., Mandal, G., Purohit, S., Gupta, A., & Bhattacharyya, A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.002 · Cited by 31
Regulation of Chemokine–Receptor Interactions and Functions
Stone, M. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112415 · Cited by 29
Zhou, Y., Guo, L., Sun, H., Xu, J., & Ba, T. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.07.002 · Cited by 26
Meng, X., Yu, X., Dong, Q., Xu, X., Li, J., Xu, Q., Ma, J., & Changhong, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.9112 · Cited by 25
Upregulation of peripheral CD4+CXCR5+ T cells in osteosarcoma
Xiao, H. P., Luo, G., Son, H., Zhou, Y., & Zheng, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-1686-6 · Cited by 23
Adam, L., Zoldan, K., Hofmann, M., Schultheiß, M., Bettinger, D., Neumann‐Haefelin, C., Thimme, R., & Boettler, T. (2018) · Hepatology Communications · doi:10.1002/hep4.1226 · Cited by 22
Circulating levels of chemokines in psoriasis
Lima, X. T. V., de Oliveira, R. T. D., Braga, F. G., Magalhães, R. F., Mamoni, R. L., & Blotta, M. H. S. L. (2014) · Autoimmunity · doi:10.3109/08916934.2014.947476 · Cited by 21
Long, S., Ma, L., Wang, D., & Shang, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5991 · Cited by 18
Ignacio, R. M. C., Lee, E.-S., Wilson, A. J., Beeghly-Fadiel, A. C., Whalen, M. M., & Son, D. (2018) · Immune Network · doi:10.4110/in.2018.18.e47 · Cited by 15
Mitkin, N. A., Muratova, A. M., Sharonov, G. V., Korneev, K. V., Sviriaeva, E. N., Mazurov, D. V., Schwartz, A. M., & Kuprash, D. V. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.10.003 · Cited by 14
Zhang, Y., Yu, K., Hu, S., Lou, Y., Liu, C., Xu, J., Li, R., Zhang, X., Wang, H., & Han, B. (2016) · Oncotarget · doi:10.18632/oncotarget.13031 · Cited by 13
Sun, W., Qiu, Z., Huang, W., & Cao, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7843 · Cited by 13
Thurneysen, S., Cheng, P. F., Nagel, H. W., Kunz, M., Jaberg-Bentele, N. F., Nägeli, M., Ziegler, M., Guenova, E., Goldinger, S. M., Mangana, J., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14727 · Cited by 10
Zhao, S., Fang, F., Tang, X., Dou, J., Wang, W., Zheng, X., Sun, L., & Zhang, A. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.05.001 · Cited by 9
Cited by
Zhao, S., Mi, Y., Guan, B., Zheng, B., Wei, P., Gu, Y., Zhang, Z., Cai, S., Xu, Y., Li, X., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00991-2 · Cited by 778
Hornburg, M., Desbois, M., Lu, S., Guan, Y., Lo, A. A., Kaufman, S., Elrod, A., Lotstein, A., DesRochers, T. M., Munoz-Rodriguez, J. L., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.004 · Cited by 383
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
Chung, M. K. Y., Gong, L., Kwong, D. L., Lee, V. H., Lee, A. W., Guan, X., Kam, N., & Dai, W. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217341 · Cited by 73
MR1 overexpression correlates with poor clinical prognosis in glioma patients
Kubica, P., Lara-Velazquez, M., Bam, M., Siraj, S., Ong, I., Liu, P., Priya, R., Salamat, S., Brutkiewicz, R. R., & Dey, M. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab034 · Cited by 20
Metadata
- Authors
- Kazanietz, M. G., Durando, M., & Cooke, M.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2019-07-12
- Volume
- 10
- Pages
- 471-471
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2959190003
- Cited by
- 356
- References
- 132
- FWCI
- 19.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.